Petmed Express (PETS) has released an update to notify the public and investors about a regulation fd disclosure.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Due to a restatement issue, the company will be postponing the submission of its Quarterly Report for the quarter ending December 31, 2023. In response to the delay, they will submit a late filing notification to the SEC. The disclosed information in this report is not considered officially filed for regulatory purposes and won’t be included in future securities filings.
For further insights into PETS stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.